Second-half execution now matters as management lowered full-year sales growth guidance to 2%-3%. [10]
| Quarter | Q2 FY26 |
|---|---|
| Length | 49 minutes |
| EPS | $0.26 |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q4 FY25 · Q2 FY25
All CRI earnings · Back to CRI overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.